These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 11086282

  • 61. [Resistance of Escherichia coli isolated from the urinary tract to amoxicillin-clavulanic acid and other antibiotics].
    Ferjani A, Marzouk M, Ben Moussa F, Boukadida J.
    Med Mal Infect; 2010 Mar; 40(3):161-4. PubMed ID: 19616395
    [Abstract] [Full Text] [Related]

  • 62. Levofloxacin vs. azithromycin pharmacodynamic activity against S. pneumoniae and H. influenzae with decreased susceptibility to amoxicillin/clavulanic acid.
    Alou L, Aguilar L, Sevillano D, Giménez MJ, González N, Echeverría O, Torrico M, Martín JE, Valdés L, Prieto J.
    J Chemother; 2007 Dec; 19(6):670-2. PubMed ID: 18230548
    [Abstract] [Full Text] [Related]

  • 63.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 64. Achieving bacterial eradication using pharmacokinetic/pharmacodynamic principles.
    Dagan R.
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S21-6. PubMed ID: 12839704
    [Abstract] [Full Text] [Related]

  • 65. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504
    [Abstract] [Full Text] [Related]

  • 66. Does the degree of penicillin susceptibility of Streptococcus pneumoniae affect the bactericidal activity of co-amoxiclav versus oral cephalosporins at physiological concentrations? An in vitro pharmacodynamic simulation.
    Prieto J, Giménez MJ, Balcabao IP, Gómez-Lus ML, Aguilar L.
    J Chemother; 1999 Oct; 11(5):345-8. PubMed ID: 10632379
    [Abstract] [Full Text] [Related]

  • 67. Determination of the pharmacodynamic profile of daptomycin against Streptococcus pneumoniae isolates with varying susceptibility to penicillin in a murine thigh infection model.
    Dandekar PK, Tessier PR, Williams P, Zhang C, Nightingale CH, Nicolau DP.
    Chemotherapy; 2004 Apr; 50(1):11-6. PubMed ID: 15084799
    [Abstract] [Full Text] [Related]

  • 68. Overview of newer antimicrobial formulations for overcoming pneumococcal resistance.
    Craig WA.
    Am J Med; 2004 Aug 02; 117 Suppl 3A():16S-22S. PubMed ID: 15360093
    [Abstract] [Full Text] [Related]

  • 69. [Antibacterial activity of clarithromycin and its hydroxylated derivative and two other macrolides against thirty strains of Streptococcus pneumoniae].
    Ploy MC, Mounier M, Denis F.
    Pathol Biol (Paris); 1994 May 02; 42(5):379-84. PubMed ID: 7824300
    [Abstract] [Full Text] [Related]

  • 70. Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
    Andes D, Craig WA.
    Antimicrob Agents Chemother; 2006 Jan 02; 50(1):243-9. PubMed ID: 16377693
    [Abstract] [Full Text] [Related]

  • 71. Antibiotic-resistant pneumococci--facts and fiction.
    Appelbaum PC.
    J Chemother; 1994 Sep 02; 6 Suppl 4():7-15; discussion 23-4. PubMed ID: 7861213
    [Abstract] [Full Text] [Related]

  • 72. Antibacterial effects of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae strains for which MICs are high, in an in vitro pharmacokinetic model.
    MacGowan AP, Noel AR, Rogers CA, Bowker KE.
    Antimicrob Agents Chemother; 2004 Jul 02; 48(7):2599-603. PubMed ID: 15215115
    [Abstract] [Full Text] [Related]

  • 73. [Kinetics of ofloxacin-amoxicillin and ofloxacin-clavulanic acid combinations against pathogenic bacteria of the respiratory tract].
    Caillon J, Juvin ME, Pirault JL, Drugeon HB.
    Pathol Biol (Paris); 1988 May 02; 36(5):414-9. PubMed ID: 3043337
    [Abstract] [Full Text] [Related]

  • 74. [Antimicrobial activity of amoxicillin versus amoxicillin/clavulanic acids. In vitro study against S aureus, H influenzae and A baumanii strains].
    Trucco O, Prado V, Garreaud C, Paya E.
    Rev Med Chil; 1993 Aug 02; 121(8):916-22. PubMed ID: 8296100
    [Abstract] [Full Text] [Related]

  • 75. [Choice of antibiotics in lower respiratory infections: what does pharmacodynamics bring? Clinical application of pharmacodynamic data].
    Goldstein F.
    Presse Med; 1998 Sep 02; 27 Suppl 4():22-3. PubMed ID: 9798483
    [No Abstract] [Full Text] [Related]

  • 76. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P, Vallée E, Azoulay-Dupuis E, Bourget P, Bédos JP, Bauchet J, Pocidalo JJ.
    Antimicrob Agents Chemother; 1994 Sep 02; 38(9):1953-8. PubMed ID: 7811003
    [Abstract] [Full Text] [Related]

  • 77. Proof of concept: performance testing in models.
    Craig WA.
    Clin Microbiol Infect; 2004 Apr 02; 10 Suppl 2():12-7. PubMed ID: 14759229
    [Abstract] [Full Text] [Related]

  • 78. In vitro activity and pharmacodynamics of oral beta-lactam antibiotics against Streptococcus pneumoniae from southeast Missouri.
    Kays MB, Wood KK, Miles DO.
    Pharmacotherapy; 1999 Nov 02; 19(11):1308-14. PubMed ID: 10555936
    [Abstract] [Full Text] [Related]

  • 79. Differences between the activity of penicillin, amoxycillin, and co-amoxyclav against 5,252 Streptococcus pneumoniae isolates tested in the Alexander Project 1992-1996.
    Butler DL, Gagnon RC, Miller LA, Poupard JA, Felmingham D, Grüneberg RN.
    J Antimicrob Chemother; 1999 Jun 02; 43(6):777-82. PubMed ID: 10404316
    [Abstract] [Full Text] [Related]

  • 80. Treatment of acute bacterial rhinosinusitis caused by antimicrobial-resistant Streptococcus pneumoniae.
    Anon JB.
    Am J Med; 2004 Aug 02; 117 Suppl 3A():23S-28S. PubMed ID: 15360094
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.